Angiogenesis and angiogenic mediators in haematological malignancies.
about
Usefulness of magnetic resonance imaging as a prognostic variable in myelodysplastic syndromes.Angiogenesis in B-cell chronic lymphocytic leukemia: methods of study, clinical significance and prognostic implications.The optimal management of polycythaemia vera.Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model.Biological and clinical heterogeneity of B-cell chronic lymphocytic leukemia.Bone marrow angiogenesis and progression in multiple myeloma: clinical significance and therapeutic approach.Tumor angiogenesis as a target for dietary cancer preventionAngiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17.Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo.Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphomaLevels of bone marrow microvessel density are crucial for evaluating the status of acute myeloid leukemia.Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features.Increased microvascular network in bone marrow of HIV-positive haemophilic patients.Elevated plasma levels of vascular endothelial growth factor is associated with marked splenomegaly in chronic myeloid leukemia.Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL).Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.A morphometric study of bone marrow angiogenesis in hairy cell leukaemia with clinicopathological correlations.Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis.Angiogenesis-related growth factors and cytokines in the serum of patients with B non-Hodgkin lymphoma; relation to clinical features and response to treatment.Prognostic significance of serum proangiogenic molecules in patients with de novo non-Hodgkin lymphomas
P2860
Q33417646-B95A27BC-625F-45FA-B0AC-0139F50FDB09Q34430232-E612464B-A116-4D58-B425-53602D2B50EDQ34527669-2B9DB1C4-319E-46A1-8ACB-DCFFC248BC03Q35103092-44EBF23B-8819-4246-B852-FB56047E0F77Q35104372-1F39689C-BA18-42B4-8A74-423BD947659DQ35175287-8DA4C25F-2F4F-48C4-B2D6-9B9F0E635A46Q35250910-9A9E3C14-B73E-435D-82EC-8E1A4BD67451Q35994847-99B9E1AE-37F6-4B67-ABE7-429623EC0B03Q36226553-105D1C09-BAA3-4511-B73D-81D06D9516B2Q36644266-DEE1F51F-D7EE-4400-95FE-E4715D822B42Q36644593-2D503990-783B-490B-A922-7A53DA3DF296Q40741428-99CDC4F0-DE36-4CDE-95AB-C25D954B8282Q44803743-2C172ED6-CAA0-4F3C-A798-D1523CDFC9F4Q45010584-50493190-92F3-4092-90A0-3AF35B4F26DDQ46786377-53218124-8821-448A-9ABC-670A73E78D49Q46830786-D53D4907-50A0-4DD6-97C5-08F633C12DA3Q46849209-7F76D9E9-CF2C-42AC-B8E8-171495444DDDQ47645420-0826F3E4-97BE-425A-91F2-FEE3EDA4B2E6Q51810088-67BD4296-22AA-430D-895B-0E78A9558341Q53222523-A9CD5CC9-26EE-422B-BE0E-E05E709EC50BQ58914680-33DE51DD-8ACB-4D90-BFBD-8C5B352F81DD
P2860
Angiogenesis and angiogenic mediators in haematological malignancies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Angiogenesis and angiogenic mediators in haematological malignancies.
@ast
Angiogenesis and angiogenic mediators in haematological malignancies.
@en
Angiogenesis and angiogenic mediators in haematological malignancies.
@nl
type
label
Angiogenesis and angiogenic mediators in haematological malignancies.
@ast
Angiogenesis and angiogenic mediators in haematological malignancies.
@en
Angiogenesis and angiogenic mediators in haematological malignancies.
@nl
prefLabel
Angiogenesis and angiogenic mediators in haematological malignancies.
@ast
Angiogenesis and angiogenic mediators in haematological malignancies.
@en
Angiogenesis and angiogenic mediators in haematological malignancies.
@nl
P2860
P1476
Angiogenesis and angiogenic mediators in haematological malignancies.
@en
P2093
P2860
P356
10.1046/J.1365-2141.2000.02104.X
P407
P577
2000-10-01T00:00:00Z